Search results
Results from the WOW.Com Content Network
Anti-Saccharomyces cerevisiae antibodies (ASCAs) are antibodies against antigens presented by the cell wall of the yeast Saccharomyces cerevisiae. These antibodies are directed against oligomannose sequences α-1,3 Man (α-1,2 Man α-1,2 Man) n (n = 1 or 2). [ 1 ]
S. cerevisiae invasive infections, however, are much rarer than invasive infections caused by Candida albicans [76] [82] even in patients weakened by cancer. [82] S. cerevisiae causes 1% to 3.6% nosocomial cases of fungemia. [81] A comprehensive review of S. cerevisiae invasive infection cases found all patients to have at least one ...
Saccharomycotina is a subdivision (subphylum) of the division (phylum) Ascomycota in the kingdom Fungi. [2] [3] It comprises most of the ascomycete yeasts.The members of Saccharomycotina reproduce by budding and they do not produce ascocarps (fruiting bodies).
A subunit vaccine is a vaccine that contains purified parts of the pathogen that are antigenic, or necessary to elicit a protective immune response. [1] [2] Subunit vaccine can be made from dissembled viral particles in cell culture or recombinant DNA expression, [3] in which case it is a recombinant subunit vaccine.
Saccharomycetes belongs to the Ascomycota division of the kingdom Fungi.It is the only class in the subdivision Saccharomycotina, the budding yeasts.Saccharomycetes contains a single order, Saccharomycetales.
Replication cycle of L-A helper, shown at bottom, and M28 (K28) killer viruses in S. cerevisiae. Saccharomyces cerevisiae virus L-A, also called L-A helper virus, is a member of the Totiviridae family of viruses found primarily in Saccharomyces cerevisiae. [3] Its discovery in the 1970s was the main starting point of research on yeast virology. [4]
For bacteria with a polysaccharide coating, like Haemophilus influenzae type b, the best way to prevent infection is to use a conjugate vaccine. [1] A conjugate vaccine is a type of subunit vaccine which combines a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.
Postvaccinal encephalitis (PVE) is a rare complication which was associated with vaccination with vaccinia virus during the worldwide smallpox eradication campaign. [1] With mortality ranging between 25 – 30% it is the most severe adverse event associated with this vaccination.